You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Discover a new possible™
At Biosense Webster, Inc. we have one goal - to help those with cardiac arrhythmias live the lives they want.
Products
Advanced 3D mapping, data integration, and technical innovation defines a range of instruments created for the treatment of cardiac arrhythmias.
Research
Clinical research and evidence from the field of electrophysiology, cardiac arrhythmias, and atrial fibrillation.
Education
Education programs that inspire excellence for electrophysiologists, fellows, proctors, and allied professionals.
Products
3D Navigation
The CARTO® 3 System is an advanced 3D mapping system with integration, scalability, and insights, supporting electrophysiologists in making optimal treatment decisions.
Products
Therapeutic Catheters
Designed to achieve the level and duration of power necessary to optimize lesion creation.
Products
Diagnostic Catheters
Gain insights and confirm diagnosis of all arrhythmias with a wide range of diagnostic catheters that offer seamless integration with the innovative CARTO® 3 System.
Products
Ultrasound Solutions
A range of ultrasound catheters, including one that is fully integrated with the CARTO® 3 System, offering comprehensive visualization of the target cardiac anatomy, bringing manageability to complex cases.
Products
Access Products
Designed to help meet the challenges of transseptal access by providing a smooth crossing profile, as well as stability and maneuverability during catheter ablation.
Products
Generators
Simplified radiofrequency ablation with the ability to personalize and store preset preferences creating an intuitive user experience that is fully integrated with CARTO® 3 System.
Products
Data Solutions
CARTONET™ is a cloud-based smart storage solution that gives electrophysiologists and electrophysiology lab administrators the ability to review, analyze and share their CARTO® 3 System cases and case data with the goal of helping to improve procedure efficiency, lab efficiency and patient outcomes.
Clinical Evidence
You are entering a rotating card carousel. Navigate the items by using the previous/next buttons.
Discover a New Possible in AF Ablation
From paroxysmal to persistent AF, Biosense Webster ablation solutions allow electrophysiologists to optimize their approach for long-term effectiveness.
PRECEPT Prospective, Multicenter, Nonrandomized Study
PRECEPT proved safety/effectiveness of persistent AF ablation with contact-force sensing THERMOCOOL SMARTTOUCH® SF Catheter and CARTO VISITAG™ Module using a tailored PVI-only/PVI+ approach.
ICE in Cardiac Arrhythmia Ablation Meta-Analysis
Systematic literature review and meta-analysis showed that ICE use in cardiac arrhythmia catheter ablation is associated with significant reductions in procedure/fluoroscopy times and fluoroscopy dose.
Cardiac Perforation With Catheter Ablation
Retrospective, observational cohort study found that use of intracardiac echocardiography (ICE) during AF ablation leads to 5x lower odds of cardiac perforation.
Smart SF Study
The multicenter, nonrandomized SMART SF study demonstrated the long-term safety/efficiency of the THERMOCOOL SMARTTOUCH® SF Catheter with CARTO VISITAG™ Module in paroxysmal AF ablation.
News
You are entering a rotating card carousel. Navigate the items by using the previous/next buttons.
Disclosures
The CARTO VISITAG™ Module provides access to data collected during the application of RF energy. The data does not indicate the effectiveness of RF energy application. CARTO VISITAG™ Module settings are user defined based on the user’s clinical experience and medical judgment. Biosense Webster, Inc. does not recommend any settings for the CARTO VISITAG™ Module.
THERMOCOOL® Navigation Catheters are indicated for the treatment of recurrent drug/device refractory sustained monomorphic ventricular tachycardia (VT) due to prior myocardial infarction (MI) in adults.
137655-220628 ©Biosense Webster, Inc. 2022 Last Updated on 8/17/2022.